quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:05:00·79d
PRRelease
OrthoPediatrics Corp. logo

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

KIDS· OrthoPediatrics Corp.
Health Care
Original source

Companies

  • KIDS
    OrthoPediatrics Corp.
    Health Care

Recent analyst ratings

  • Jan 27UpdateTD Cowen$23.00
  • Dec 10UpdateCanaccord Genuity$24.00
  • Apr 7UpdateLake Street$37.00
  • Jan 25UpdateTruist$31.00
  • Mar 3UpdateNeedham$65.00
  • Dec 22UpdateBTIG$68.00

Related

  • SEC3d
    SEC Form DEF 14A filed by OrthoPediatrics Corp.
  • SEC3d
    SEC Form DEFA14A filed by OrthoPediatrics Corp.
  • PR7d
    OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
  • SEC22d
    OrthoPediatrics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
  • PR23d
    OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
  • INSIDER37d
    COO and CFO Hite Fred was granted 77,405 shares and sold $224,129 worth of shares (12,993 units at $17.25), increasing direct ownership by 30% to 277,477 units (SEC Form 4)
  • INSIDER37d
    Pres. Trauma & Def. Correction Hauser Joseph W was granted 65,700 shares and sold $148,281 worth of shares (8,596 units at $17.25), increasing direct ownership by 41% to 194,767 units (SEC Form 4)
  • INSIDER37d
    President and CEO Bailey David R sold $336,979 worth of shares (19,535 units at $17.25), decreasing direct ownership by 6% to 298,020 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022